Dashboard
Manage Tickers

INDPIndaptus Therapeutics, Inc.

Nasdaq indaptusrx.com


$ 2.43 $ 0.03 (1.23 %)    

Friday, 14-Jun-2024 14:05:15 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 2.47
$ 2.43
$ 0.00 x 0
$ 0.00 x 0
$ 2.43 - $ 2.43
$ 1.56 - $ 4.08
16,029
na
20.85M
$ 1.31
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-13-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

indaptus-therapeutics-to-present-at-sting--tlr-targeted-therapies-summit-jun-19-20
Indaptus Therapeutics To Present At STING ...
06/11/2024 12:07:05

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
06/07/2024 12:08:00

indaptus-therapeutics-to-present-new-positive-data-on-decoy20-at-next-gen-immuno-oncology-conference
Indaptus Therapeutics To Present New Posit...
06/04/2024 12:27:33

Indaptus Therapeutics, Inc, (NASDAQ:INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and...

indaptus-therapeutics-announces-new-data-from-ongoing-phase-1-trial-of-decoy20-latest-data-from-first-and-second-cohorts-support-companys-pulse-prime-approach-demonstrating-rapid-clearance-broad-immune-activation-and-encouraging-safety-profile
Indaptus Therapeutics Announces New Data F...
06/03/2024 12:39:45

Latest data from first and second cohorts support Company's 'pulse-prime' approach, demonstrating rapid clearance, ...

indaptus-therapeutics-presents-new-cohort-data-confirming-original-pulse-prime-hypothesis-via-phase-1-clinical-trial-of-decoy20-at-the-asco-annual-meeting
Indaptus Therapeutics Presents New Cohort ...
05/29/2024 12:27:37

Indaptus Therapeutics, Inc, (NASDAQ:INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
05/22/2024 16:31:29

indaptus-therapeutics-first-patient-received-multiple-doses-of-decoy20-the-companys-broad-based-pulse-prime-immuno-oncology-therapy-for-advanced-solid-tumors
Indaptus Therapeutics First Patient Receiv...
05/22/2024 12:16:19

First-in-human trial confirms "Pulse-Prime" hypothesis targeting stimulation of innate and adaptive immune systemsInves...

indaptus-therapeutics-q1-eps-045-misses-044-estimate
Indaptus Therapeutics Q1 EPS $(0.45) Misse...
05/08/2024 12:26:36

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate ...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 20:31:10

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
05/01/2024 20:31:24

hc-wainwright--co-reiterates-buy-on-indaptus-therapeutics-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Inda...
04/15/2024 10:08:24

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Indaptus Therapeutics (NASDAQ:INDP) with a Buy and maintains $...

indaptus-therapeutics-unveils-details-on-mechanism-of-action-data-that-demonstrates-the-companys-decoy-platform-induces-matures-or-activates-multiple-immune-cell-types-involved-in-anti-tumor-responses-at-aacr-research-annual-meeting
Indaptus Therapeutics Unveils Details On M...
04/11/2024 11:35:20

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
04/05/2024 12:09:50

indaptus-therapeutics-previews-mechanism-of-action-data-to-be-presented-at-the-american-association-for-cancer-research-annual-meeting
Indaptus Therapeutics Previews Mechanism O...
03/25/2024 12:41:26

Data demonstrates that Company's Decoy platform successfully induces or activates multiple immune celltypes involved in ant...

indaptus-therapeutics-q4-earnings-insights
Indaptus Therapeutics: Q4 Earnings Insights
03/13/2024 13:40:12

indaptus-therapeutics-fy-eps-183-beats-195-estimate-cash-balance-of-134m-will-provide-runway-through-q3-of-2024
Indaptus Therapeutics FY EPS $(1.83) Beats...
03/13/2024 11:39:27

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(1.83) per share which beat the analyst consensus estimate of...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
03/11/2024 13:05:55

indaptus-therapeutics-announces-results-from-second-cohort-of-phase-1-trial-initiates-multi-dose-cohort
Indaptus Therapeutics Announces Results Fr...
03/04/2024 12:33:08

• Positive data following completion of second cohort of Phase 1 trial of Decoy 20 leads independent Safety Review Committee to...

why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Butterfly Network Shares Are Trading L...
02/29/2024 19:00:01

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

why-okta-shares-are-trading-higher-by-around-24-here-are-20-stocks-moving-premarket
Why Okta Shares Are Trading Higher By Arou...
02/29/2024 13:04:20

Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-e...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)